tiprankstipranks
Radiopharm Theranostics Limited Sponsored ADR (RADX)
NASDAQ:RADX
US Market
RADX
Radiopharm Theranostics Limited Sponsored ADR
RESEARCH TOOLSreports
Want to see RADX full AI Analyst Report?

Radiopharm Theranostics Limited Sponsored ADR (RADX) Ratios

63 Followers

Radiopharm Theranostics Limited Sponsored ADR Ratios

RADX's free cash flow for Q4 2025 was AU$0.12. For the 2025 fiscal year, RADX's free cash flow was decreased by AU$ and operating cash flow was AU$-28.47. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
 1.16 1.16 2.67 1.30 3.46
Quick Ratio
 1.16 1.16 2.67 1.30 3.46
Cash Ratio
 0.22 0.22 1.95 1.06 3.42
Solvency Ratio
 -1.42 -1.43 -0.88 -1.00 -1.34
Operating Cash Flow Ratio
 -2.79 -2.73 -2.45 -1.31 -1.26
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
AU$ -15.88MAU$ -15.89MAU$ -3.76MAU$ -21.83MAU$ 6.85M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 2.44 2.44 1.93 2.56 1.32
Debt Service Coverage Ratio
 -573.93 -607.45 -586.06 -68.72 -1.93
Interest Coverage Ratio
 -626.93 -607.93 -584.59 -56.96 -2.13
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 <0.01 <0.01 <0.01 0.50 9.17
Net Debt to EBITDA
 0.06 0.06 0.76 0.42 1.50
Profitability Margins
Gross Profit Margin
-39.41%-77.67%1.08%100.00%100.00%
EBIT Margin
-2545.78%-2468.62%-1050.63%-15777.22%-237174.08%
EBITDA Margin
-2496.85%-2468.62%-1050.43%-14732.44%-203412.51%
Operating Profit Margin
-2545.78%-2468.62%-1050.63%-12238.44%-225527.71%
Pretax Profit Margin
-2219.93%-2055.58%-1052.43%-15992.07%-343048.15%
Net Profit Margin
-1992.46%-1992.46%-1055.27%-16024.28%-343550.89%
Continuous Operations Profit Margin
-2053.61%-2053.61%-1055.27%-16024.28%-343550.89%
Net Income Per EBT
89.75%96.93%100.27%100.20%100.15%
EBT Per EBIT
87.20%83.27%100.17%130.67%152.11%
Return on Assets (ROA)
-91.71%-89.70%-44.34%-66.56%-36.39%
Return on Equity (ROE)
-144.24%-218.50%-85.60%-170.50%-48.19%
Return on Capital Employed (ROCE)
-170.88%-162.07%-53.35%-67.24%-26.38%
Return on Invested Capital (ROIC)
-158.08%-161.91%-53.35%-67.24%-26.38%
Return on Tangible Assets
-251.00%-245.50%-96.08%-208.94%-111.11%
Earnings Yield
-195.68%-75.42%-78.40%-140.32%-116.28%
Efficiency Ratios
Receivables Turnover
 0.16 0.16 0.35 0.30 0.16
Payables Turnover
 0.71 0.88 0.57 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 59.99 58.68 67.96 4.92 5.60
Asset Turnover
 0.05 0.05 0.04 <0.01 <0.01
Working Capital Turnover Ratio
 0.16 0.19 0.24 0.07 0.00
Cash Conversion Cycle
 1.78K 1.94K 400.15 1.20K 2.33K
Days of Sales Outstanding
 2.30K 2.35K 1.04K 1.20K 2.33K
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 517.07 414.81 644.60 0.00 0.00
Operating Cycle
 2.30K 2.35K 1.04K 1.20K 2.33K
Cash Flow Ratios
Operating Cash Flow Per Share
 -4.49 -4.37 -5.28 -17.84 -9.73
Free Cash Flow Per Share
 -1.93 0.00 -5.28 -17.84 -37.52
CapEx Per Share
 2.56 4.37 0.00 0.00 27.80
Free Cash Flow to Operating Cash Flow
 0.43 0.00 1.00 1.00 3.86
Dividend Paid and CapEx Coverage Ratio
 -1.75 -1.00 0.00 0.00 -0.35
Capital Expenditure Coverage Ratio
 -1.75 -1.00 0.00 0.00 -0.35
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
 -19.07 -19.07 -10.09 -76.78 -1.12K
Free Cash Flow Yield
-119.84%0.00%-74.93%-67.24%-146.62%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.51 -1.33 -1.34 -0.71 -0.86
Price-to-Sales (P/S) Ratio
 6.84 26.42 13.46 114.19 2.95K
Price-to-Book (P/B) Ratio
 1.14 2.90 1.09 1.22 0.41
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.83 0.00 -1.33 -1.49 -0.68
Price-to-Operating Cash Flow Ratio
 -0.53 -1.39 -1.33 -1.49 -2.63
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 0.10 0.02 -0.08 0.00
Price-to-Fair Value
 1.14 2.90 1.09 1.22 0.41
Enterprise Value Multiple
 -0.21 -1.01 -0.52 -0.35 0.05
Enterprise Value
 14.78M 67.39M 19.79M 15.60M -888.26K
EV to EBITDA
 -0.21 -1.01 -0.52 -0.35 0.05
EV to Sales
 5.34 24.89 5.45 52.12 -100.58
EV to Free Cash Flow
 -0.65 0.00 -0.54 -0.68 0.02
EV to Operating Cash Flow
 -0.28 -1.31 -0.54 -0.68 0.09
Tangible Book Value Per Share
 1.90 1.89 -0.53 -16.87 6.76
Shareholders’ Equity Per Share
 2.10 2.09 6.46 21.83 61.76
Tax and Other Ratios
Effective Tax Rate
 0.07 <0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
 0.24 0.23 0.52 0.23 <0.01
Net Income Per Share
 -4.70 -4.57 -5.53 -37.22 -29.76
Tax Burden
 0.90 0.97 1.00 1.00 1.00
Interest Burden
 0.87 0.83 1.00 1.01 1.45
Research & Development to Revenue
 19.21 0.00 7.57 58.68 467.08
SG&A to Revenue
 5.86 5.86 4.55 50.86 1.23K
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.96 0.96 0.00 0.48 0.33
Currency in AUD